Figure 1From: Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)SIDAG. Presented is the chemical structure of SIDAG (1,1'-bis- [4-sulfobutyl]indotricarbocyanine-5,5'-dicarboxylic acid diglucamide monosodium).Back to article page